Aeovian gets $55M for tuberous sclerosis complex, to explore prospects in obesity
Aeovian gets $55M for tuberous sclerosis complex, to explore prospects in obesity
Aeovian gets $55M for tuberous sclerosis complex, to explore prospects in obesity
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.